ロード中...
Next generation therapies change the landscape in melanoma
Melanoma is among the leading causes of years of life lost due to cancer. Current chemotherapy and cytokine-based immunotherapy approaches benefit only a small percentage of patients with advanced disease. However, the recent discovery of mutations in the gene encoding the serine-threonine kinase B-...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Faculty of 1000 Ltd
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3096880/ https://ncbi.nlm.nih.gov/pubmed/21654923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/M3-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|